Because of the important role of intra-tumoral T cells in eliminating tumor cells, and the potential for reduction of T-cell function by engagement of SIRPγ, the lack of binding of F05 to human T cells provides a distinct advantage over other available agents. The gene discussed is SIRPG; the disease is neoplasm.